Trial intelligence / Profile preview

Efficacy of Stannous Fluoride Toothpaste for Dentine Hypersensitivity in China

NCT05750745Completed

Sponsor
Haleon
Start
May 2023
Primary completion
Sep 2023
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

Randomised, single-blind trial of stannous fluoride in dentin hypersensitivity (DH) (3 arms), sponsored by Haleon. Primary endpoint: Adjusted Mean Change From Baseline in Schiff Sensitivity Score at 12 weeks. Started May 2023; status: completed.

02

Drugs

stannous fluoride
03

Conditions

dentin hypersensitivity (DH)

Beyond the preview

Go deeper on NCT05750745.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05750745.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call